REVIEW
Published on 21 Jan 2025
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
doi 10.3389/fonc.2024.1501950
- 224 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- BCL-2 Family Inhibitors in Hematologic Malignancies
BCL-2 Family Inhibitors in Hematologic Malignancies
1,423
Total downloads
4,851
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 09 Dec 2024
Efficacy and safety of hypomethylating agents in the treatment of AML/MDS patients relapsed post allogenetic hematopoietic stem cell transplantation
doi 10.3389/fonc.2024.1465334
- 474 views
MINI REVIEW
Published on 04 Nov 2024
Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma
doi 10.3389/fonc.2024.1490202
- 932 views
BRIEF RESEARCH REPORT
Published on 08 Apr 2024
Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity
doi 10.3389/fonc.2024.1394393
- 1,160 views
Published in
Frontiers in Oncology
- Hematologic Malignancies
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.
Impact
- 4,851Topic views
- 2,572Article views
- 1,423Article downloads